Stericycle (NASDAQ: SRCL) is one of 20 publicly-traded companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it weigh in compared to its peers? We will compare Stericycle to similar businesses based on the strength of its risk, dividends, profitability, valuation, earnings, institutional ownership and analyst recommendations.
This table compares Stericycle and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current recommendations for Stericycle and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Stericycle currently has a consensus price target of $75.90, suggesting a potential upside of 13.39%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 7.71%. Given Stericycle’s higher probable upside, equities research analysts clearly believe Stericycle is more favorable than its peers.
Volatility & Risk
Stericycle has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, Stericycle’s peers have a beta of 0.77, suggesting that their average stock price is 23% less volatile than the S&P 500.
Insider & Institutional Ownership
94.6% of Stericycle shares are held by institutional investors. Comparatively, 53.0% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by institutional investors. 3.5% of Stericycle shares are held by insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Stericycle and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Stericycle||$3.56 billion||$206.35 million||-119.54|
|Stericycle Competitors||$850.65 million||$28.19 million||164.03|
Stericycle has higher revenue and earnings than its peers. Stericycle is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Stericycle beats its peers on 7 of the 13 factors compared.
Stericycle Company Profile
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.